Legend Biotech Corporation (NASDAQ:LEGN) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. Legend Biotech Corporation (NASDAQ:LEGN) tops our list of the best healthcare stocks ...

Former Collingwood boss Jeff Browne says he is now in 'deep remission' and 'firing' after once being told his blood cancer ...

Tumbler Ridge is the type of town where everyone knows everyone. And as the tiny mountain community reels from one of Canada’s worst school shootings in decades, it is the type of place where ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the fourth quarter and full year ended ...

The 18-year-old fatally shot her mother and stepbrother as well as six people at a school, before killing herself. Her motive ...

His passing came after a five-year battle with multiple myeloma, a cancer that begins in the plasma cells in the bone marrow, according to a friend of his.

STUDIO CITY, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today welcomed Stephen L. Houff, MD, as the newest member of the IMF Board of Directors.

Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple myeloma treatment paradigm, the drug is still finding ways to consolidate its ...

What can we learn from Canada’s pivot away from the U.S.? By Katrin Bennhold I’m the host of The World. I’m still processing how the world changed last week. President Trump’s wild threats against ...

In a new study published in Cancer, researchers from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine’s Department of Pathology examine this disparity more closely, ...

After a short delay and concerns of potential intervention from senior officials, the FDA has issued a draft guidance for the industry on the potential use of minimal residual disease (MRD) and ...

The FDA issued draft guidance Jan. 21 proposing the use of minimal residual disease and complete response as primary endpoints to support accelerated approval of drugs for multiple myeloma. The draft ...